» Articles » PMID: 22980195

Acetaminophen-induced Liver Injury in Rats and Mice: Comparison of Protein Adducts, Mitochondrial Dysfunction, and Oxidative Stress in the Mechanism of Toxicity

Overview
Specialties Pharmacology
Toxicology
Date 2012 Sep 18
PMID 22980195
Citations 195
Authors
Affiliations
Soon will be listed here.
Abstract

Acetaminophen (APAP) overdose is the most common cause of acute liver failure in the West. In mice, APAP hepatotoxicity can be rapidly induced with a single dose. Because it is both clinically relevant and experimentally convenient, APAP intoxication has become a popular model of liver injury. Early data demonstrated that rats are resistant to APAP toxicity. As a result, mice are the preferred species for mechanistic studies. Furthermore, recent work has shown that the mechanisms of APAP toxicity in humans are similar to mice. Nevertheless, some investigators still use rats. New mechanistic information from the last forty years invites a reevaluation of the differences between these species. Comparison may provide interesting insights and confirm or exclude the rat as an option for APAP studies. To this end, we treated rats and mice with APAP and measured parameters of liver injury, APAP metabolism, oxidative stress, and activation of the c-Jun N-terminal kinase (JNK). Consistent with earlier data, we found that rats were highly resistant to APAP toxicity. Although overall APAP metabolism was similar in both species, mitochondrial protein adducts were significantly lower in rats. Accordingly, rats also had less oxidative stress. Finally, while mice showed extensive activation and mitochondrial translocation of JNK, this could not be detected in rat livers. These data support the hypothesis that mitochondrial dysfunction is critical for the development of necrosis after APAP treatment. Because mitochondrial damage also occurs in humans, rats are not a clinically relevant species for studies of APAP hepatotoxicity.

Citing Articles

The effects of alpha-pinene against paracetamol-induced liver damage in male rats.

Rahimi K, Rezaie A, Allahverdi Y, Shahriari P, Taheri Mirghaed M Physiol Rep. 2025; 13(3):e70227.

PMID: 39903586 PMC: 11793005. DOI: 10.14814/phy2.70227.


Altered drug metabolism and increased susceptibility to fatty liver disease in a mouse model of myotonic dystrophy.

Dewald Z, Adesanya O, Bae H, Gupta A, Derham J, Chembazhi U Nat Commun. 2024; 15(1):9062.

PMID: 39433769 PMC: 11494077. DOI: 10.1038/s41467-024-53378-z.


Effect of ferroptosis inhibitors in a murine model of acetaminophen-induced liver injury.

Adelusi O, Etemadi Y, Akakpo J, Ramachandran A, Jaeschke H J Biochem Mol Toxicol. 2024; 38(8):e23791.

PMID: 39082238 PMC: 11382325. DOI: 10.1002/jbt.23791.


The role of exosomal lncRNAs in acetaminophen-induced induced liver injury in SD rats.

Yang Z, Shi L, Zheng M, Hou M, Zhou M, Su N Noncoding RNA Res. 2024; 9(4):1190-1202.

PMID: 39026604 PMC: 11254842. DOI: 10.1016/j.ncrna.2024.05.011.


HMGB1 as an extracellular pro-inflammatory cytokine: Implications for drug-induced organic damage.

Yuan J, Guo L, Ma J, Zhang H, Xiao M, Li N Cell Biol Toxicol. 2024; 40(1):55.

PMID: 39008169 PMC: 11249443. DOI: 10.1007/s10565-024-09893-2.


References
1.
McGill M, Yan H, Ramachandran A, Murray G, Rollins D, Jaeschke H . HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology. 2011; 53(3):974-82. PMC: 3073317. DOI: 10.1002/hep.24132. View

2.
Agarwal R, MacMillan-Crow L, Rafferty T, Saba H, Roberts D, Fifer E . Acetaminophen-induced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase. J Pharmacol Exp Ther. 2011; 337(1):110-6. PMC: 3063736. DOI: 10.1124/jpet.110.176321. View

3.
Lauterburg B, Mitchell J . Regulation of hepatic glutathione turnover in rats in vivo and evidence for kinetic homogeneity of the hepatic glutathione pool. J Clin Invest. 1981; 67(5):1415-24. PMC: 370708. DOI: 10.1172/jci110170. View

4.
Jaeschke H, McGill M, Ramachandran A . Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev. 2012; 44(1):88-106. PMC: 5319847. DOI: 10.3109/03602532.2011.602688. View

5.
Jaeschke H, Williams C, McGill M, Farhood A . Herbal extracts as hepatoprotectants against acetaminophen hepatotoxicity. World J Gastroenterol. 2010; 16(19):2448-50. PMC: 2874154. DOI: 10.3748/wjg.v16.i19.2448. View